Ann: Investor Briefing, page-212

I only got to listen to the first half hour of the presentation but the thing that stuck in my head, was the impression that work in the vaccine space might actually be the next or at least an early source of revenue.
To me it seems to be a bit of a sleeper topic with few details released from the company thus far and not getting as much air play as some of the other streams, but if there's one thing more urgent than an accurate Covid-19 test, it's a vaccine. I don't believe we've had a standalone announcement for this yet but very keen to see the progress in this space.